Delivery Order SPE2DB20D1100-SPE2DB25FB9S3
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWEW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,058,212 units of Vyvanse 40 mg capsules, with a ceiling value of $2,290.97. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 4,566,690 units of the prescription medication Vyvanse 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $3,907.70 and an ultimate completion date of December 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and...
This is a $1,082.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,560,716,962 units of Vyvanse 40 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,399.72 firm fixed price delivery order contract is for the supply of 4,567,582,710 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of 4,562,001 units of the medication Vyvanse 40 mg capsules. The contract has a ceiling value of $10,009.14, with an ultimate completion date of August 28, 2023. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,552,572,418 units of Vyvanse 40 mg capsules. The contract has a ceiling value of $4,034.48 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00 through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,455,636 units of Vyvanse 40 mg capsules. The $5,237.60 firm-fixed-price delivery order contract has a completion date of January 26, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,728,779 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $2,675.40 and a period of performance through December 17, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,991.21, is a delivery order for 4,566,373,534 units of the medication Vyvanse 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of November 8, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,803.74 Firm Fixed Price Delivery Order is for the supply of 4,565,796,976 units of the prescription medication Vyvanse (40 mg capsules) with a completion date of September 16, 2024. This is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to...